nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A critical analysis of publication rates of national oncology meeting abstracts in Turkey
|
Kilickap, S. |
|
2018 |
4 |
1 |
p. 24-28 |
artikel |
2 |
Acute promyelocytic leukemia after anthracycline containing chemotherapy for breast cancer: Case report and review of the literature
|
Mirili, Cem |
|
2018 |
4 |
1 |
p. 62-64 |
artikel |
3 |
Art therapies in cancer — A non-negligible beauty and benefit
|
Bilgin, Ezgi |
|
2018 |
4 |
1 |
p. 47-48 |
artikel |
4 |
Assessment of the efficiency of Brentuximab Vedotin in patients with pulmonary Hodgkin Lymphoma by the mean of neutrophil to lymphocyte ratio
|
Erdem, Gokhan |
|
2018 |
4 |
1 |
p. 29-34 |
artikel |
5 |
Clinical predictive factors associated with pathologic complete response in locally advanced rectal cancer
|
Bozkaya, Yakup |
|
2018 |
4 |
1 |
p. 5-10 |
artikel |
6 |
EDB
|
|
|
2018 |
4 |
1 |
p. ii-iii |
artikel |
7 |
Evaluation of dynamic serum thiol/disulfide homeostasis in locally advanced and metastatic gastric cancer
|
Hizal, Mutlu |
|
2018 |
4 |
1 |
p. 1-4 |
artikel |
8 |
Is the frequency of primary cutaneous melanoma increasing in Turkey? An evaluation of the experiences of two dermatology centers
|
Baykal, Can |
|
2018 |
4 |
1 |
p. 19-23 |
artikel |
9 |
Merkel cell carcinoma with axillary metastasis; a case report of a rare disease
|
Culcu, Serdar |
|
2018 |
4 |
1 |
p. 53-55 |
artikel |
10 |
Moleculer nutritional immunology and cancer
|
Çehreli, Rüksan |
|
2018 |
4 |
1 |
p. 40-46 |
artikel |
11 |
Pulmonary MALT lymphoma with underlying interstitial lung disease: A case report and rewiev of the literature
|
Mirili, Cem |
|
2018 |
4 |
1 |
p. 56-59 |
artikel |
12 |
Retesting the psychometric characteristics of the European cancer research and treatment organization’s quality of life questionnaire palliative care 15 Turkish version (EQRTC QLQ C15-PAL) and evaluating the influencing factors
|
Yavuzsen, Tugba |
|
2018 |
4 |
1 |
p. 35-39 |
artikel |
13 |
Serum endocan level and its prognostic significance in breast cancer patients
|
Ates, Ozturk |
|
2018 |
4 |
1 |
p. 15-18 |
artikel |
14 |
Short term real world safety data of pertuzumab use in HER2 targeted treatment of metastatic breast cancer
|
Esin, Ece |
|
2018 |
4 |
1 |
p. 11-14 |
artikel |
15 |
The role of FOLFOXIRI in chemorefractory metastatic colorectal cancer patients
|
Yildiz, Ibrahim |
|
2018 |
4 |
1 |
p. 60-61 |
artikel |
16 |
Treatment of locally advanced, unresectable or medically inoperable stage III non-small-cell lung cancer; the past, present and future of chemoradiotherapy
|
Calikusu, Zuleyha |
|
2018 |
4 |
1 |
p. 49-52 |
artikel |